CDT
Price:
$1.82
Market Cap:
$2.46M
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.
Industry
Biotechnology
IPO Date
2022-03-28
Stock Exchange
NASDAQ
Ticker
CDT
According to CDT Equity Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.66. This represents a change of -94.25% compared to the average of 28.95 of the last 4 quarters.
The mean historical Current Ratio of CDT Equity Inc. over the last ten years is 0.99. The current 1.66 Current Ratio has changed 16.63% with respect to the historical average. Over the past ten years (40 quarters), CDT's Current Ratio was at its highest in in the December 2024 quarter at 111.37. The Current Ratio was at its lowest in in the December 2022 quarter at 0.
Average
0.99
Median
0.40
Minimum
0
Maximum
3.18
Discovering the peaks and valleys of CDT Equity Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 3.18
Minimum Annual Increase = -100.00%
Minimum Annual Current Ratio = 0
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 0.25 | -92.06% |
| 2023 | 3.18 | Infinity% |
| 2022 | 0 | -100.00% |
The current Current Ratio of CDT Equity Inc. (CDT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.15
5-year avg
0.99
10-year avg
0.99
CDT Equity Inc.’s Current Ratio is less than Hepion Pharmaceuticals, Inc. (7.60), greater than Longevity Health Holdings Inc. (0.42), greater than ZyVersa Therapeutics, Inc. (0.08), greater than Envoy Medical, Inc. (0.64), greater than SCWorx Corp. (1.13), less than Lixte Biotechnology Holdings, Inc. (1.84), greater than NewGenIvf Group Limited (1.17), less than Petros Pharmaceuticals, Inc. (2.22), greater than Concord Medical Services Holdings Limited (0.42), less than Enveric Biosciences, Inc. (2.43),
| Company | Current Ratio | Market cap |
|---|---|---|
| 7.60 | $697.22K | |
| 0.42 | $548.98K | |
| 0.08 | $1.13M | |
| 0.64 | $17.59M | |
| 1.13 | $1.01M | |
| 1.84 | $19.34M | |
| 1.17 | $544.91K | |
| 2.22 | $373.92K | |
| 0.42 | $531.49K | |
| 2.43 | $3.65M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CDT Equity Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CDT Equity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is CDT Equity Inc.'s Current Ratio?
How is the Current Ratio calculated for CDT Equity Inc. (CDT)?
What is the highest Current Ratio for CDT Equity Inc. (CDT)?
What is the 3-year average Current Ratio for CDT Equity Inc. (CDT)?
What is the 5-year average Current Ratio for CDT Equity Inc. (CDT)?
How does the current Current Ratio for CDT Equity Inc. (CDT) compare to its historical average?